Clinical Trial

Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD

Study acronym: THALEX
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare physical ability of patients with transfusion-dependent β-thalassemia to control subjects. The main question it aims to answer is: is there a difference in power output at first lactate threshold between patients with transfusion-dependent β-thalassemia and control subjects during maximal incremental exercise test. Participants will have to realise differents exams including measurement of body compposition, maximal incremental exercise test, vertical jump, vasoreactivity test, blood sampling, quality of life questionnaires and neuromuscular assessments.
Trial Details
NCT Number NCT07207577
Lead Sponsor Centre Hospitalier Metropole Savoie
Collaborators: Université Savoie Mont Blanc, Laboratoire de Psychologie et NeuroCognition (LPNC), Université Grenoble Alpes
Conditions Beta Thalassemia Transfusion Dependent
Enrollment 36 participants
Start Date 2025-09-04
Primary Completion 2028-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2025-10-06